NFS1 as a Candidate Prognostic Biomarker for Gastric Cancer Correlated with Immune Infiltrates
Our results suggest that NFS1 may be a potential biomarker for the diagnosis and prediction of prognosis and immunotherapy efficacy in GC.
Authors
- You Jiang (ORCID: https://orcid.org/0000-0001-9204-6724)
- Yuee Wu
- Zhengguang Wang
- Wenbo Li (ORCID: https://orcid.org/0000-0002-9126-2529)
- Jun Zhang (ORCID: https://orcid.org/0000-0002-3444-3550)
- Kun Liu (ORCID: https://orcid.org/0000-0002-0938-1378)
Institutions
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
- Third People's Hospital of Hefei (CN)
Publication Details
- Journal
- International Journal of General Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/ijgm.s444443
- Citations
- 6
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 3.44